Skip to main content
Erschienen in: Journal of Endocrinological Investigation 7/2014

01.07.2014 | Original Article

High prevalence of hypovitaminosis D in Sicilian children affected by growth hormone deficiency and its improvement after 12 months of replacement treatment

verfasst von: A. Ciresi, F. Cicciò, C. Giordano

Erschienen in: Journal of Endocrinological Investigation | Ausgabe 7/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Although the correlation between vitamin D and growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis is documented, as of date, few and conflicting studies have prospectively analyzed vitamin D before and after GH treatment. Our aim was to evaluate as to how the condition of GH deficiency (GHD) or GH treatment influences vitamin D in children.

Methods

Eighty Sicilian GHD children (M/F 58/22; mean age 10.3 years), grouped according to the season of evaluation in group A (June–September; 41 children) and group B (November–February; 39 children), were evaluated at baseline and after 12 months of GH treatment.

Results

Twenty-eight children (35 %) were vitamin D insufficient and 32 (40 %) deficient at baseline, and lower vitamin D levels were found in group B than in A (17.3 ± 5.3 vs. 31.1 ± 11.1 ng/ml; p < 0.001). A positive correlation between vitamin D and baseline GH levels (p < 0.001) was found. After 12 months, increased vitamin D was found both in all children (34.4 ± 16.4 vs. 24.5 ± 11.1 ng/ml; p = 0.002) and in group A (38.5 ± 14 vs. 31.1 ± 11.1 ng/ml; p < 0.001) and B (30 ± 17.7 vs. 17.3 ± 5.3 ng/ml; p < 0.001). Overall, only 25 (31 %) children remained insufficient and 15 (19 %) deficient, with an increase in prevalence of children with normal levels (p = 0.001).

Conclusions

Our data demonstrated a very high prevalence of hypovitaminosis D in Sicilian GHD children, with an improvement after 12 months of GH treatment. Vitamin D assessment should therefore be considered routinely in GHD children both at diagnosis and during the follow-up.
Literatur
1.
Zurück zum Zitat Johansen JS, Pedersen SA, Jørgensen JO, Riis BJ, Christiansen C, Christiansen JS, Skakkebaek NE (1990) Effects of growth hormone (GH) on plasma bone Gla protein in GH-deficient adults. J Clin Endocrinol Metab 70(4):916–919PubMedCrossRef Johansen JS, Pedersen SA, Jørgensen JO, Riis BJ, Christiansen C, Christiansen JS, Skakkebaek NE (1990) Effects of growth hormone (GH) on plasma bone Gla protein in GH-deficient adults. J Clin Endocrinol Metab 70(4):916–919PubMedCrossRef
2.
Zurück zum Zitat Binnerts A, Swart GR, Wilson JH, Hoogerbrugge N, Pols HA, Birkenhager JC, Lamberts SW (1992) The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition. Clin Endocrinol (Oxf) 37(1):79–87CrossRef Binnerts A, Swart GR, Wilson JH, Hoogerbrugge N, Pols HA, Birkenhager JC, Lamberts SW (1992) The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition. Clin Endocrinol (Oxf) 37(1):79–87CrossRef
3.
Zurück zum Zitat Schlemmer A, Johansen JS, Pedersen SA, Jørgensen JO, Hassager C, Christiansen C (1991) The effect of growth hormone (GH) therapy on urinary pyridinoline cross-links in GH-deficient adults. Clin Endocrinol (Oxf) 35(6):471–476CrossRef Schlemmer A, Johansen JS, Pedersen SA, Jørgensen JO, Hassager C, Christiansen C (1991) The effect of growth hormone (GH) therapy on urinary pyridinoline cross-links in GH-deficient adults. Clin Endocrinol (Oxf) 35(6):471–476CrossRef
4.
Zurück zum Zitat Henry HL (2011) Regulation of vitamin D metabolism. Best Pract Res Clin Endocrinol Metab 25(4):531–541PubMedCrossRef Henry HL (2011) Regulation of vitamin D metabolism. Best Pract Res Clin Endocrinol Metab 25(4):531–541PubMedCrossRef
5.
Zurück zum Zitat Bianda T, Hussain MA, Glatz Y, Bouillon R, Froesch ER, Schmid C (1997) Effects of short-term insulin-like growth factor-I or growth hormone treatment on bone turnover, renal phosphate reabsorption and 1,25 dihydroxyvitamin D3 production in healthy man. J Intern Med 241(2):143–150PubMedCrossRef Bianda T, Hussain MA, Glatz Y, Bouillon R, Froesch ER, Schmid C (1997) Effects of short-term insulin-like growth factor-I or growth hormone treatment on bone turnover, renal phosphate reabsorption and 1,25 dihydroxyvitamin D3 production in healthy man. J Intern Med 241(2):143–150PubMedCrossRef
6.
Zurück zum Zitat Marcus R, Butterfield G, Holloway L, Gilliland L, Baylink DJ, Hintz RL, Sherman BM (1990) Effects of short term administration of recombinant human growth hormone to elderly people. J Clin Endocrinol Metab 70(2):519–527PubMedCrossRef Marcus R, Butterfield G, Holloway L, Gilliland L, Baylink DJ, Hintz RL, Sherman BM (1990) Effects of short term administration of recombinant human growth hormone to elderly people. J Clin Endocrinol Metab 70(2):519–527PubMedCrossRef
7.
Zurück zum Zitat Kamenický P, Blanchard A, Gauci C, Salenave S, Letierce A, Lombès M, Brailly-Tabard S, Azizi M, Prié D, Souberbielle JC, Chanson P (2012) Pathophysiology of renal calcium handling in acromegaly: what lies behind hypercalciuria? J Clin Endocrinol Metab 97(6):2124–2133PubMedCrossRef Kamenický P, Blanchard A, Gauci C, Salenave S, Letierce A, Lombès M, Brailly-Tabard S, Azizi M, Prié D, Souberbielle JC, Chanson P (2012) Pathophysiology of renal calcium handling in acromegaly: what lies behind hypercalciuria? J Clin Endocrinol Metab 97(6):2124–2133PubMedCrossRef
8.
Zurück zum Zitat Amato G, Izzo G, La Montagna G, Bellastella A (1996) Low dose recombinant human growth hormone normalizes bone metabolism and cortical bone density and improves trabecular bone density in growth hormone deficient adults without causing adverse effects. Clin Endocrinol (Oxf) 45(1):27–32CrossRef Amato G, Izzo G, La Montagna G, Bellastella A (1996) Low dose recombinant human growth hormone normalizes bone metabolism and cortical bone density and improves trabecular bone density in growth hormone deficient adults without causing adverse effects. Clin Endocrinol (Oxf) 45(1):27–32CrossRef
9.
Zurück zum Zitat Wei S, Tanaka H, Seino Y (1998) Local action of exogenous growth hormone and insulin-like growth factor-I on dihydroxyvitamin D production in LLC-PK1 cells. Eur J Endocrinol 139(4):454–460PubMedCrossRef Wei S, Tanaka H, Seino Y (1998) Local action of exogenous growth hormone and insulin-like growth factor-I on dihydroxyvitamin D production in LLC-PK1 cells. Eur J Endocrinol 139(4):454–460PubMedCrossRef
10.
Zurück zum Zitat Ameri P, Giusti A, Boschetti M, Bovio M, Teti C, Leoncini G, Ferone D, Murialdo G, Minuto F (2013) Vitamin D increases circulating IGF1 in adults: potential implication for the treatment of GH deficiency. Eur J Endocrinol 169(6):767–772PubMedCrossRef Ameri P, Giusti A, Boschetti M, Bovio M, Teti C, Leoncini G, Ferone D, Murialdo G, Minuto F (2013) Vitamin D increases circulating IGF1 in adults: potential implication for the treatment of GH deficiency. Eur J Endocrinol 169(6):767–772PubMedCrossRef
11.
Zurück zum Zitat Soliman AT, Al Khalaf F, Alhemaidi N, Al Ali M, Al Zyoud M, Yakoot K (2008) Linear growth in relation to the circulating concentrations of insulin-like growth factor I, parathyroid hormone, and 25-hydroxy vitamin D in children with nutritional rickets before and after treatment: endocrine adaptation to vitamin D deficiency. Metab Clin Exp 57:95–102PubMedCrossRef Soliman AT, Al Khalaf F, Alhemaidi N, Al Ali M, Al Zyoud M, Yakoot K (2008) Linear growth in relation to the circulating concentrations of insulin-like growth factor I, parathyroid hormone, and 25-hydroxy vitamin D in children with nutritional rickets before and after treatment: endocrine adaptation to vitamin D deficiency. Metab Clin Exp 57:95–102PubMedCrossRef
12.
Zurück zum Zitat Marshall WA, Tanner JM (1969) Variations in pattern of pubertal changes in girls. Arch Dis Child 44(235):230–291 Marshall WA, Tanner JM (1969) Variations in pattern of pubertal changes in girls. Arch Dis Child 44(235):230–291
13.
Zurück zum Zitat Growth Hormone Research Society (2000) Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. J Clin Endocrinol Metab 85:3990–3993 Growth Hormone Research Society (2000) Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. J Clin Endocrinol Metab 85:3990–3993
14.
Zurück zum Zitat Norman AW, Bouillon R, Whiting SJ, Vieth R, Lips P (2007) 13th workshop consensus for vitamin D nutritional guidelines. J Steroid Biochem Mol Biol 103:204–205PubMedCrossRefPubMedCentral Norman AW, Bouillon R, Whiting SJ, Vieth R, Lips P (2007) 13th workshop consensus for vitamin D nutritional guidelines. J Steroid Biochem Mol Biol 103:204–205PubMedCrossRefPubMedCentral
15.
Zurück zum Zitat McKenna MJ, Freaney R (1998) Secondary hyperparathyroidism in the elderly: means to defining hypovitaminosis D. Osteoporos Int 8(Suppl 2):S3–S6PubMedCrossRef McKenna MJ, Freaney R (1998) Secondary hyperparathyroidism in the elderly: means to defining hypovitaminosis D. Osteoporos Int 8(Suppl 2):S3–S6PubMedCrossRef
16.
Zurück zum Zitat Arabi A, El Rassi R, El-Hajj Fuleihan G (2010) Hypovitaminosis D in developing countries-prevalence, risk factors and outcomes. Nat Rev Endocrinol 6(10):550–561PubMedCrossRef Arabi A, El Rassi R, El-Hajj Fuleihan G (2010) Hypovitaminosis D in developing countries-prevalence, risk factors and outcomes. Nat Rev Endocrinol 6(10):550–561PubMedCrossRef
17.
Zurück zum Zitat Guillemant J, Taupin P, Le HT, Taright N, Allemandou A, Pérès G, Guillemant S (1999) Vitamin D status during puberty in French healthy male adolescents. Osteoporos Int 10(3):222–225PubMedCrossRef Guillemant J, Taupin P, Le HT, Taright N, Allemandou A, Pérès G, Guillemant S (1999) Vitamin D status during puberty in French healthy male adolescents. Osteoporos Int 10(3):222–225PubMedCrossRef
18.
Zurück zum Zitat Lehtonen-Veromaa M, Möttönen T, Irjala K, Kärkkäinen M, Lamberg-Allardt C, Hakola P, Viikari J (1999) Vitamin D intake is low and hypovitaminosis D common in healthy 9- to 15-year-old Finnish girls. Eur J Clin Nutr 53(9):746–751PubMedCrossRef Lehtonen-Veromaa M, Möttönen T, Irjala K, Kärkkäinen M, Lamberg-Allardt C, Hakola P, Viikari J (1999) Vitamin D intake is low and hypovitaminosis D common in healthy 9- to 15-year-old Finnish girls. Eur J Clin Nutr 53(9):746–751PubMedCrossRef
19.
Zurück zum Zitat Guillemant J, Allemandou A, Cabrol S, Pérès G, Guillemant S (1998) Vitamin D status in the adolescent: seasonal variations and effects of winter supplementation with vitamin D3. Arch Pediatr 5(11):1211–1215PubMedCrossRef Guillemant J, Allemandou A, Cabrol S, Pérès G, Guillemant S (1998) Vitamin D status in the adolescent: seasonal variations and effects of winter supplementation with vitamin D3. Arch Pediatr 5(11):1211–1215PubMedCrossRef
20.
Zurück zum Zitat Mithal A, Wahl DA, Bonjour JP, Burckhardt P, Dawson-Hughes B, Eisman JA, El-Hajj Fuleihan G, Josse RG, Lips P, Morales-Torres J, IOF Committee of Scientific Advisors (CSA), Nutrition Working Group (2009) Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int 20(11):1807–1820PubMedCrossRef Mithal A, Wahl DA, Bonjour JP, Burckhardt P, Dawson-Hughes B, Eisman JA, El-Hajj Fuleihan G, Josse RG, Lips P, Morales-Torres J, IOF Committee of Scientific Advisors (CSA), Nutrition Working Group (2009) Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int 20(11):1807–1820PubMedCrossRef
21.
Zurück zum Zitat Prentice A (2008) Vitamin D deficiency: a global perspective. Nutr Rev 66(10 Suppl 2):S153–S164PubMedCrossRef Prentice A (2008) Vitamin D deficiency: a global perspective. Nutr Rev 66(10 Suppl 2):S153–S164PubMedCrossRef
22.
Zurück zum Zitat Bouillon R, Carmeliet G, Daci E, Segaert S, Verstuyf A (1998) Vitamin D metabolism and action. Osteoporos Int 8(Suppl 2):S13–S19PubMedCrossRef Bouillon R, Carmeliet G, Daci E, Segaert S, Verstuyf A (1998) Vitamin D metabolism and action. Osteoporos Int 8(Suppl 2):S13–S19PubMedCrossRef
23.
Zurück zum Zitat Norman AW (2008) From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr 88(2):491S–499SPubMed Norman AW (2008) From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr 88(2):491S–499SPubMed
24.
Zurück zum Zitat Halhali A, Díaz L, Sánchez I, Garabédian M, Bourges H, Larrea F (1999) Effects of IGF-I on 1,25-dihydroxyvitamin D(3) synthesis by human placenta in culture. Mol Hum Reprod 5(8):771–776PubMedCrossRef Halhali A, Díaz L, Sánchez I, Garabédian M, Bourges H, Larrea F (1999) Effects of IGF-I on 1,25-dihydroxyvitamin D(3) synthesis by human placenta in culture. Mol Hum Reprod 5(8):771–776PubMedCrossRef
25.
Zurück zum Zitat Ameri P, Giusti A, Boschetti M, Murialdo G, Minuto F, Ferone D (2013) Interactions between vitamin D and IGF-I: from physiology to clinical practice. Clin Endocrinol (Oxf) 79(4):457–463CrossRef Ameri P, Giusti A, Boschetti M, Murialdo G, Minuto F, Ferone D (2013) Interactions between vitamin D and IGF-I: from physiology to clinical practice. Clin Endocrinol (Oxf) 79(4):457–463CrossRef
27.
Zurück zum Zitat Parkinson C, Kassem M, Heickendorff L, Flyvbjerg A, Trainer PJ (2003) Pegvisomant-induced serum insulin-like growth factor-I normalization in patients with acromegaly returns elevated markers of bone turnover to normal. J Clin Endocrinol Metab 88(12):5650–5655PubMedCrossRef Parkinson C, Kassem M, Heickendorff L, Flyvbjerg A, Trainer PJ (2003) Pegvisomant-induced serum insulin-like growth factor-I normalization in patients with acromegaly returns elevated markers of bone turnover to normal. J Clin Endocrinol Metab 88(12):5650–5655PubMedCrossRef
28.
Zurück zum Zitat Wei S, Tanaka H, Kubo T, Ono T, Kanzaki S, Seino Y (1997) Growth hormone increases serum 1,25-dihydroxyvitamin D levels and decreases 24,25-dihydroxyvitamin D levels in children with growth hormone deficiency. Eur J Endocrinol 136(1):45–51PubMedCrossRef Wei S, Tanaka H, Kubo T, Ono T, Kanzaki S, Seino Y (1997) Growth hormone increases serum 1,25-dihydroxyvitamin D levels and decreases 24,25-dihydroxyvitamin D levels in children with growth hormone deficiency. Eur J Endocrinol 136(1):45–51PubMedCrossRef
29.
Zurück zum Zitat Saggese G, Baroncelli GI, Bertelloni S, Cinquanta L, Di Nero G (1993) Effects of long-term treatment with growth hormone on bone and mineral metabolism in children with growth hormone deficiency. J Pediatr 122(1):37–45PubMedCrossRef Saggese G, Baroncelli GI, Bertelloni S, Cinquanta L, Di Nero G (1993) Effects of long-term treatment with growth hormone on bone and mineral metabolism in children with growth hormone deficiency. J Pediatr 122(1):37–45PubMedCrossRef
30.
Zurück zum Zitat Hansen TB, Brixen K, Vahl N, Jørgensen JO, Christiansen JS, Mosekilde L, Hagen C (1996) Effects of 12 months of growth hormone (GH) treatment on calciotropic hormones, calcium homeostasis, and bone metabolism in adults with acquired GH deficiency: a double blind, randomized, placebo-controlled study. J Clin Endocrinol Metab 81(9):3352–3359PubMed Hansen TB, Brixen K, Vahl N, Jørgensen JO, Christiansen JS, Mosekilde L, Hagen C (1996) Effects of 12 months of growth hormone (GH) treatment on calciotropic hormones, calcium homeostasis, and bone metabolism in adults with acquired GH deficiency: a double blind, randomized, placebo-controlled study. J Clin Endocrinol Metab 81(9):3352–3359PubMed
31.
Zurück zum Zitat El-Hajj Fuleihan G, Nabulsi M, Choucair M, Salamoun M, Hajj Shahine C, Kizirian A, Tannous R (2001) Hypovitaminosis D in healthy schoolchildren. Pediatrics 107(4):E53PubMedCrossRef El-Hajj Fuleihan G, Nabulsi M, Choucair M, Salamoun M, Hajj Shahine C, Kizirian A, Tannous R (2001) Hypovitaminosis D in healthy schoolchildren. Pediatrics 107(4):E53PubMedCrossRef
32.
Zurück zum Zitat Carnevale V, Modoni S, Pileri M, Di Giorgio A, Chiodini I, Minisola S, Vieth R, Scillitani A (2001) Longitudinal evaluation of vitamin D status in healthy subjects from southern Italy: seasonal and gender differences. Osteoporos Int 12(12):1026–1030PubMedCrossRef Carnevale V, Modoni S, Pileri M, Di Giorgio A, Chiodini I, Minisola S, Vieth R, Scillitani A (2001) Longitudinal evaluation of vitamin D status in healthy subjects from southern Italy: seasonal and gender differences. Osteoporos Int 12(12):1026–1030PubMedCrossRef
33.
Zurück zum Zitat Wright NM, Papadea N, Wentz B, Hollis B, Willi S, Bell NH (1997) Increased serum 1,25-dihydroxyvitamin D after growth hormone administration is not parathyroid hormone-mediated. Calcif Tissue Int 61(2):101–103PubMedCrossRef Wright NM, Papadea N, Wentz B, Hollis B, Willi S, Bell NH (1997) Increased serum 1,25-dihydroxyvitamin D after growth hormone administration is not parathyroid hormone-mediated. Calcif Tissue Int 61(2):101–103PubMedCrossRef
34.
Zurück zum Zitat Ahmad AM, Thomas J, Clewes A, Hopkins MT, Guzder R, Ibrahim H, Durham BH, Vora JP, Fraser WD (2003) Effects of growth hormone replacement on parathyroid hormone sensitivity and bone mineral metabolism. J Clin Endocrinol Metab 88(6):2860–2868PubMedCrossRef Ahmad AM, Thomas J, Clewes A, Hopkins MT, Guzder R, Ibrahim H, Durham BH, Vora JP, Fraser WD (2003) Effects of growth hormone replacement on parathyroid hormone sensitivity and bone mineral metabolism. J Clin Endocrinol Metab 88(6):2860–2868PubMedCrossRef
35.
Zurück zum Zitat Lombardi G, Di Somma C, Vuolo L, Guerra E, Scarano E, Colao A (2010) Role of IGF-I on PTH effects on bone. J Endocrinol Invest 33(7 Suppl):22–26PubMed Lombardi G, Di Somma C, Vuolo L, Guerra E, Scarano E, Colao A (2010) Role of IGF-I on PTH effects on bone. J Endocrinol Invest 33(7 Suppl):22–26PubMed
36.
Zurück zum Zitat Bianda T, Glatz Y, Bouillon R, Froesch ER, Schmid C (1998) Effects of short-term insulin-like growth factor-I (IGF-I) or growth hormone (GH) treatment on bone metabolism and on production of 1,25-dihydroxycholecalciferol in GH-deficient adults. J Clin Endocrinol Metab 83(1):81–87PubMed Bianda T, Glatz Y, Bouillon R, Froesch ER, Schmid C (1998) Effects of short-term insulin-like growth factor-I (IGF-I) or growth hormone (GH) treatment on bone metabolism and on production of 1,25-dihydroxycholecalciferol in GH-deficient adults. J Clin Endocrinol Metab 83(1):81–87PubMed
37.
Zurück zum Zitat Beshyah SA, Thomas E, Kyd P, Sharp P, Fairney A, Johnston DG (1994) The effect of growth hormone replacement therapy in hypopituitary adults on calcium and bone metabolism. Clin Endocrinol (Oxf) 40(3):383–391CrossRef Beshyah SA, Thomas E, Kyd P, Sharp P, Fairney A, Johnston DG (1994) The effect of growth hormone replacement therapy in hypopituitary adults on calcium and bone metabolism. Clin Endocrinol (Oxf) 40(3):383–391CrossRef
38.
Zurück zum Zitat Savić L, Savić D (2008) Serum calcium and phosphorus concentration and alkaline phosphatase activity in healthy children during growth and development. Med Pregl 61(7–8):393–399PubMed Savić L, Savić D (2008) Serum calcium and phosphorus concentration and alkaline phosphatase activity in healthy children during growth and development. Med Pregl 61(7–8):393–399PubMed
Metadaten
Titel
High prevalence of hypovitaminosis D in Sicilian children affected by growth hormone deficiency and its improvement after 12 months of replacement treatment
verfasst von
A. Ciresi
F. Cicciò
C. Giordano
Publikationsdatum
01.07.2014
Verlag
Springer International Publishing
Erschienen in
Journal of Endocrinological Investigation / Ausgabe 7/2014
Elektronische ISSN: 1720-8386
DOI
https://doi.org/10.1007/s40618-014-0084-7

Weitere Artikel der Ausgabe 7/2014

Journal of Endocrinological Investigation 7/2014 Zur Ausgabe

Endocrinology and Art

Orazio Marinali (1643–1720)

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.